376980 — Wanted Lab Balance Sheet
0.000.00%
- KR₩37bn
- KR₩18bn
- KR₩37bn
- 47
- 46
- 22
- 29
Annual balance sheet for Wanted Lab, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 5,258 | 36,380 | 37,642 | 9,096 | 23,618 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,198 | 1,992 | 2,776 | 2,311 | 2,370 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 7,067 | 38,893 | 41,276 | 30,336 | 26,437 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 6,366 | 5,303 | 4,081 | 2,697 | 3,644 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 14,484 | 45,709 | 56,895 | 46,986 | 50,188 |
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 37,320 | 6,147 | 7,915 | 6,196 | 7,630 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 43,923 | 12,657 | 13,933 | 12,162 | 13,694 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| ESOP Debt Guarantee | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | -29,439 | 33,053 | 42,962 | 34,824 | 36,495 |
| Total Liabilities & Shareholders' Equity | 14,484 | 45,709 | 56,895 | 46,986 | 50,188 |
| Total Common Shares Outstanding |